An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

BullFrog AI's bfLEAP platform identified biomarkers linked to improved survival in pancreatic adenocarcinoma patients treated ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

A new vaccine designed to combat cancer cells in patients with colorectal and pancreatic cancer showed promising results in its phase 1 trial. Researchers at the University of California said 21 out ...

Research shows that gastrointestinal cancers — including stomach, liver, esophageal, pancreatic, and colorectal cancers — account for about 26% of all cancers worldwide and 35% of all cancer-related ...

ELI-002 2P vaccine targets KRAS mutation, showing reduced relapse risk and improved survival in pancreatic and colorectal cancer patients. Two-thirds of study participants exhibited a strong immune ...

A novel cancer vaccine that stimulates the immune system to target one of the most common cancer-driving mutations has shown encouraging early results in patients with pancreatic and colorectal cancer ...

The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...

Please provide your email address to receive an email when new articles are posted on . Rates of pancreatic adenocarcinoma increased significantly among younger individuals than older ones. Colorectal ...

Now, researchers are turning to an unexpected source for early PDAC detection: faecal samples. While analysing poo might seem ...